<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NHL) consists of a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Population-based data on the familial risk for specific histopathologic subtypes have not been established </plain></SENT>
<SENT sid="2" pm="."><plain>Such data are useful for clinical counseling and for searching <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> subtypes sharing common genetic pathways </plain></SENT>
<SENT sid="3" pm="."><plain>We used the Swedish Family-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> Database to calculate standardized incidence ratios (SIRs) for histopathology-specific subtypes of NHL in 4455 offspring with NHL whose parents or siblings were affected with different types of lymphoproliferative <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>A familial history of NHL significantly increased the risk for NHL (SIRparent = 1.8; SIRsibling = 1.9) and for diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (SIRparent = 2.3), follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (SIRsibling = 2.3), and B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> not otherwise specified (NOS) (SIRsibling = 3.4) </plain></SENT>
<SENT sid="5" pm="."><plain>For a parental history of histopathology-specific concordant <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, the risks were significantly increased for diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (SIR = 11.8), follicular NHL (SIR = 6.1), plasma cell <z:mp ids='MP_0009440'>myeloma</z:mp> (SIR = 2.5), and <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (SIR = 5.9) </plain></SENT>
<SENT sid="6" pm="."><plain>Familial clusters for NHL seemed stronger in females and in siblings </plain></SENT>
<SENT sid="7" pm="."><plain>Our study provides the first quantification of the familial risks for NHL by histopathology </plain></SENT>
<SENT sid="8" pm="."><plain>The present findings give evidence for a strong familial association of NHL, with little differences in the magnitude of risks for various histopathologic subtypes </plain></SENT>
<SENT sid="9" pm="."><plain>The patterns of risks in parents and siblings support the hypothesis of an <z:hpo ids='HP_0000006'>autosomal-dominant</z:hpo> component for diffuse large B-cell NHL and a recessive one for follicular NHL </plain></SENT>
</text></document>